From each company's latest annual SEC filing. Fiscal years can end on different dates.
Coca-Cola (KO) is the larger business by reported revenue: $47.9B in its fiscal year ended Dec 2025, about 3.2× KVUE's $15.1B (fiscal year ended Dec 2025). KO's net margin was 27.3% and KVUE's 9.7%. The SEC classifies them differently (Beverages; Perfumes, Cosmetics & Other Toilet Preparations); what connects them is shared exposure to the International markets research theme, not a common industry.
Figures come from each company's own SEC filings. This page compares the businesses; it is not a price target or a verdict.
| Company fact | KO | KVUE |
|---|---|---|
| Company | The Coca-Cola Company | Kenvue Inc. |
| Exchange | NYSE | NYSE |
| Headquarters | Atlanta, Georgia | — |
| Founded | 1886 | — |
| SEC industry | Beverages | Perfumes, Cosmetics & Other Toilet Preparations |
| Fiscal year-end | December 31 | January 3 |
| Latest annual filing | 10-K · 2026-02-20 | 10-K · 2026-02-20 |
| Metric | KO | KVUE |
|---|---|---|
| Revenue | $47.9B2025-01-01 to 2025-12-31 · SEC filing | $15.1B2024-12-30 to 2025-12-28 · SEC filing |
| Net income | $13.1B2025-01-01 to 2025-12-31 · SEC filing | $1.5B2024-12-30 to 2025-12-28 · SEC filing |
| Operating cash flow | $7.4B2025-01-01 to 2025-12-31 · SEC filing | $2.2B2024-12-30 to 2025-12-28 · SEC filing |
| Diluted EPS | $3.042025-01-01 to 2025-12-31 · SEC filing | $0.762024-12-30 to 2025-12-28 · SEC filing |
| Net margin | 27.3%2025-01-01 to 2025-12-31 · SEC filing | 9.7%2024-12-30 to 2025-12-28 · SEC filing |
KO: FY ending 2025-12-31 · KVUE: FY ending 2025-12-28. Figures as tagged in each issuer's SEC XBRL filing; fiscal calendars may not align.
Overlap is drawn from SEC classifications and Yield Theory research themes. It is not evidence that the companies sell to the same customers or compete product for product.
Coca-Cola is the world's largest nonalcoholic beverage company, selling sparkling drinks, water, juice, and coffee through a global bottling network. Its brand strength and international reach make it a classic defensive holding.
Kenvue makes consumer-health brands including Tylenol, Band-Aid, Listerine, and Neutrogena.
Company-specific drivers maintained by Yield Theory. Use them to decide which filing deserves deeper work; they are not predictions.
We have not yet published a company-specific driver list for KO. The primary source is Item 1 (Business) and Item 1A (Risk Factors) of its 10-K filed 2026-02-20.
We have not yet published a company-specific driver list for KVUE. The primary source is Item 1 (Business) and Item 1A (Risk Factors) of its 10-K filed 2026-02-20.
You now know KO reports about 3.2× KVUE's revenue, and KO keeps more of each dollar as net income. Those are the facts. The investment question is what each share price already assumes about their exposure to international markets, and which evidence in the next filings would prove that assumption wrong.
Members-only research
Texas has frozen new data center approvals since the summer. The vote extends that freeze, but it cannot unplug campuses that already have power. We map who is exposed, test whether the sell-off overshot and say where the real risk sits.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchStart with primary filings because fiscal calendars and accounting presentation can make superficially similar quarters incomparable. KO's fiscal year ends December 31, while KVUE's ends January 3. Normalize the reporting periods before comparing growth, margins, capital intensity, or guidance.
The current verified House and Senate snapshot contains 30 matched transaction rows for KO and 19 matched transaction rows for KVUE. These delayed, range-based disclosures can identify a filing to inspect; they do not establish motive, conviction, or a real-time trading signal.
This page does not contain licensed live prices, a valuation model, earnings estimates, portfolio constraints, or a forecast of future returns. SEC classifications can be broad, company descriptions can lag strategic change, and the latest annual filing may predate a material acquisition or divestiture. Read subsequent quarterly and current reports before making a decision.
A stronger business is not automatically the better stock. Starting valuation, expectations, capital structure, cyclicality, dilution, and the probability of each thesis determine the investment outcome. Use this comparison to frame the work, then verify the numbers in the linked filings and current company disclosures.
Not necessarily. Coca-Cola files as Beverages and Kenvue as Perfumes, Cosmetics & Other Toilet Preparations. The pair is compared because both map to the International markets research theme, not because the filings show head-to-head competition.
Coca-Cola (KO) is the larger business by reported revenue: $47.9B in its fiscal year ended Dec 2025, about 3.2× KVUE's $15.1B (fiscal year ended Dec 2025). KO's net margin was 27.3% and KVUE's 9.7%. The SEC classifies them differently (Beverages; Perfumes, Cosmetics & Other Toilet Preparations); what connects them is shared exposure to the International markets research theme, not a common industry. Each figure is the annual amount tagged in the company's own SEC XBRL filing; market value depends on live prices, which this page does not publish.
There is no context-free winner. Compare the operating exposures, filing evidence, valuation, balance sheet, and risks against the specific thesis you are testing. This page deliberately does not turn a static profile into a buy or sell recommendation.
No. Yield Theory does not republish unlicensed real-time market data. The financial figures on this page are the audited annual numbers The Coca-Cola Company and Kenvue Inc. tagged in their SEC XBRL filings. Use a regulated broker or licensed quote provider for current prices and valuation multiples.
Company classifications, fiscal year-ends, and filing links come from the SEC EDGAR submissions API snapshot refreshed 2026-11-09. Business summaries and research themes are maintained by Yield Theory.
Data snapshot: SEC EDGAR submissions API, refreshed 2026-11-09. Independent educational research; not investment advice.
KO vs KVUE compares reported results. The reports below show how we connect operating evidence to an investment thesis, its assumptions, catalysts, and risks. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included